Tryp Therapeutics TRYPF Stock
Tryp Therapeutics Price Chart
Tryp Therapeutics TRYPF Financial and Trading Overview
| Tryp Therapeutics stock price | 0.04 USD |
| Previous Close | 0.05 USD |
| Open | 0.06 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.06 - 0.06 USD |
| 52 Week Range | 0.04 - 0.18 USD |
| Volume | 10K USD |
| Avg. Volume | 16.68K USD |
| Market Cap | 6.59M USD |
| Beta (5Y Monthly) | -1.068614 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
TRYPF Valuation Measures
| Enterprise Value | 4.47M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Tryp Therapeutics Stock Price History
| Beta (5Y Monthly) | -1.068614 |
| 52-Week Change | -13.78% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.18 USD |
| 52 Week Low | 0.04 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.08 USD |
TRYPF Share Statistics
| Avg. Volume (3 month) | 16.68K USD |
| Avg. Daily Volume (10-Days) | 20.86K USD |
| Shares Outstanding | 96.42M |
| Float | 45.25M |
| Short Ratio | N/A |
| % Held by Insiders | 47.24% |
| % Held by Institutions | 0.042% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | August 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | August 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -237.49% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5840681 USD |
| Diluted EPS (ttm) | -0.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 43.84K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.17 |
| Book Value Per Share (mrq) | -0.016 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3584748 USD |
| Levered Free Cash Flow (ttm) | -1446238 USD |
Profile of Tryp Therapeutics
| Country | United States |
| State | BC |
| City | Kelowna |
| Address | 301 - 1665 Ellis Street |
| ZIP | V1Y 2B3 |
| Phone | N/A |
| Website | https://www.tryptherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Tryp Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing psilocybin-related molecules. The company's Psilocybin-For-Neuropsychiatric Disorders (PFN) program focuses on the development of synthetic psilocybin-related molecules as a new class of drug for the treatment of binge eating, chronic pain, and other indications. Its program candidate includes TRP-8803, a psilocybin-based drug product for the treatment of diseases with unmet medical needs through accelerated regulatory pathways. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Q&A For Tryp Therapeutics Stock
What is a current TRYPF stock price?
Tryp Therapeutics TRYPF stock price today per share is 0.04 USD.
How to purchase Tryp Therapeutics stock?
You can buy TRYPF shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tryp Therapeutics?
The stock symbol or ticker of Tryp Therapeutics is TRYPF.
Which industry does the Tryp Therapeutics company belong to?
The Tryp Therapeutics industry is Biotechnology.
How many shares does Tryp Therapeutics have in circulation?
The max supply of Tryp Therapeutics shares is 96.42M.
What is Tryp Therapeutics Price to Earnings Ratio (PE Ratio)?
Tryp Therapeutics PE Ratio is now.
What was Tryp Therapeutics earnings per share over the trailing 12 months (TTM)?
Tryp Therapeutics EPS is -0.03 USD over the trailing 12 months.
Which sector does the Tryp Therapeutics company belong to?
The Tryp Therapeutics sector is Healthcare.